Philips Minicare: Future on-site testing system

In the past, the period of testing - diagnosis in the treatment of diseases always requires high accuracy so it often takes a long time. This shortening of the period is considered essential, especially in emergencies. Philips has met the rapid diagnostic needs by introducing a new generation of Point-of-Care solution called Minicare.

>>> Mobile lab
>>> Quick and accurate blood tests with SpinChip

With Philips' on-site Minicare test system, a quick diagnosis by testing blood samples will take place within minutes. This mobile test system includes an analyzer with friendly interface and an alternative sampling head. Inside the analyzer is Magnotech's biosensor technology, which helps to collect test samples at picomolar doses, 500 million times smaller than the current way of collecting samples by glucose testing.

Picture 1 of Philips Minicare: Future on-site testing system
4 steps to conduct blood collection and rapid blood test

Minicare supports the analysis of many results on the same test sample, the patient no longer undergoes complex testing steps. Philips' solution is anticipated not only as a practical alternative to testing - traditional diagnosis, but it also brings many benefits to patients.

For example, patients with acute heart failure syndrome when hospitalized often experience countless tests that take a long time so that doctors can give appropriate treatment options. This will certainly threaten the lives of patients and make them more confused and stressed. The on-site test of Minicare will help doctors give faster diagnosis results, thereby improving the patient's ability to save lives.

Picture 2 of Philips Minicare: Future on-site testing system
This is an alternative test head, used in conjunction with Philips' Minicare system.How to take a blood sample will tell the doctor the desired result within minutes.

Picture 3 of Philips Minicare: Future on-site testing system
Philips Minicare promises to change current test-diagnostic methods but still ensure high accuracy.

Picture 4 of Philips Minicare: Future on-site testing system
Magnetic nanocrystals will be put into the sampling head right from the factory's production.These crystals are then automatically dispersed into the newly taken and added to the protein molecules by the guidance of the guiding molecules.

Picture 5 of Philips Minicare: Future on-site testing system
A small magnetic plate placed underneath the probe will generate a strong enough magnetic field to attract magnetic nanocrystals to the biosensor sensor surface.Here, protein molecules will be wrapped with a second layer of information molecule.

Picture 6 of Philips Minicare: Future on-site testing system
Above the sampling head there is also another magnetic plate that creates the magnetic field to pull the remaining magnetic nanocrystals towards it.By using two plates from the collection of necessary magnetic nanocrystals, it will take place more quicklyand accurately.

Picture 7 of Philips Minicare: Future on-site testing system
Magnetic nanoparticles will be retained between two magnetic plates and the number of these crystals will be measured by optical techniques based on the principle of image reflection.

Picture 8 of Philips Minicare: Future on-site testing system

Picture 9 of Philips Minicare: Future on-site testing system

Picture 10 of Philips Minicare: Future on-site testing system
In urgent cases such as patients with heart failure, on-site testing will help doctors quickly diagnose the patient's condition and provide a suitable treatment plan.The decision to open the coronary artery promptly or not will involve the ability to save patients.

The title has been changed.